Indaptus Therapeutics Stock Probability Of Bankruptcy

INDP Stock  USD 2.12  0.06  2.75%   
Indaptus Therapeutics' chance of distress is under 24% at this time. It has slight odds of undergoing some form of financial hardship in the near future. Probability of distress prediction helps decision makers evaluate Indaptus Therapeutics' chance of financial distress in relation to its going-concern outlook and evaluation. All items used in analyzing the odds of distress are taken from the Indaptus balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Indaptus Therapeutics Piotroski F Score and Indaptus Therapeutics Altman Z Score analysis.
To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.
  
As of 07/24/2024, Enterprise Value is likely to grow to about 1.7 M, while Market Cap is likely to drop slightly above 11.4 M.

Indaptus Therapeutics Company probability of distress Analysis

Indaptus Therapeutics' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Indaptus Therapeutics Probability Of Bankruptcy

    
  Less than 24%  
Most of Indaptus Therapeutics' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Indaptus Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Indaptus Therapeutics probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Indaptus Therapeutics odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Indaptus Therapeutics financial health.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Indaptus Therapeutics. If investors know Indaptus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Indaptus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.77)
Return On Assets
(0.58)
Return On Equity
(0.98)
The market value of Indaptus Therapeutics is measured differently than its book value, which is the value of Indaptus that is recorded on the company's balance sheet. Investors also form their own opinion of Indaptus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Indaptus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Indaptus Therapeutics' market value can be influenced by many factors that don't directly affect Indaptus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Indaptus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Indaptus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Indaptus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Indaptus Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Indaptus Therapeutics is extremely important. It helps to project a fair market value of Indaptus Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Indaptus Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Indaptus Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Indaptus Therapeutics' interrelated accounts and indicators.
0.920.56-0.780.020.37-0.030.240.130.92-0.030.010.60.650.370.65
0.920.81-0.880.4-0.01-0.410.36-0.261.0-0.41-0.370.840.890.660.89
0.560.81-0.790.74-0.49-0.770.32-0.670.81-0.77-0.740.980.940.960.93
-0.78-0.88-0.79-0.450.060.440.070.3-0.890.440.41-0.88-0.82-0.6-0.83
0.020.40.74-0.45-0.91-0.990.3-0.980.41-1.0-0.990.760.770.790.77
0.37-0.01-0.490.06-0.910.91-0.250.97-0.010.910.93-0.47-0.47-0.65-0.46
-0.03-0.41-0.770.44-0.990.91-0.30.99-0.411.01.0-0.77-0.78-0.84-0.78
0.240.360.320.070.3-0.25-0.3-0.290.34-0.33-0.280.220.390.370.38
0.13-0.26-0.670.3-0.980.970.99-0.29-0.260.990.99-0.67-0.67-0.78-0.66
0.921.00.81-0.890.41-0.01-0.410.34-0.26-0.42-0.380.850.890.660.89
-0.03-0.41-0.770.44-1.00.911.0-0.330.99-0.421.0-0.78-0.78-0.84-0.78
0.01-0.37-0.740.41-0.990.931.0-0.280.99-0.381.0-0.75-0.76-0.82-0.75
0.60.840.98-0.880.76-0.47-0.770.22-0.670.85-0.78-0.750.960.90.96
0.650.890.94-0.820.77-0.47-0.780.39-0.670.89-0.78-0.760.960.881.0
0.370.660.96-0.60.79-0.65-0.840.37-0.780.66-0.84-0.820.90.880.87
0.650.890.93-0.830.77-0.46-0.780.38-0.660.89-0.78-0.750.961.00.87
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Indaptus Therapeutics has a Probability Of Bankruptcy of 24.0%. This is 44.56% lower than that of the Biotechnology sector and 56.24% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 39.74% higher than that of the company.

Indaptus Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Indaptus Therapeutics' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Indaptus Therapeutics could also be used in its relative valuation, which is a method of valuing Indaptus Therapeutics by comparing valuation metrics of similar companies.
Indaptus Therapeutics is currently under evaluation in probability of bankruptcy category among its peers.

Indaptus Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Indaptus Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Indaptus Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Indaptus Fundamentals

About Indaptus Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Indaptus Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Indaptus Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Indaptus Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Indaptus Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Indaptus Stock

  0.44GILD Gilead SciencesPairCorr
  0.33KAKZF Kaspi Bank JointPairCorr
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Indaptus Stock Analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.